| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 87.15B | 94.34B | 99.73B | 99.73B | 85.16B |
| Gross Profit | 8.23B | 10.09B | 9.16B | 6.05B | 6.47B |
| EBITDA | 5.13B | 3.40B | 2.97B | 2.09B | 3.44B |
| Net Income | 2.48B | 2.08B | -70.00M | -2.05B | -1.21B |
Balance Sheet | |||||
| Total Assets | 81.11B | 78.33B | 81.18B | 82.90B | 80.16B |
| Cash, Cash Equivalents and Short-Term Investments | 17.57B | 15.23B | 12.29B | 17.28B | 19.71B |
| Total Debt | 5.78B | 2.92B | 6.86B | 9.95B | 8.62B |
| Total Liabilities | 25.01B | 25.29B | 29.91B | 34.01B | 30.38B |
| Stockholders Equity | 55.75B | 52.70B | 50.85B | 48.51B | 49.44B |
Cash Flow | |||||
| Free Cash Flow | -1.22B | 690.00M | -963.00M | -2.43B | -411.00M |
| Operating Cash Flow | 1.95B | 2.77B | 958.00M | -787.00M | 3.50B |
| Investing Cash Flow | -1.72B | 4.50B | -1.21B | -2.05B | -3.46B |
| Financing Cash Flow | 1.28B | -4.99B | -5.00B | -30.00M | -1.33B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥49.47B | 9.47 | 8.46% | 2.64% | -3.94% | 36.68% | |
75 Outperform | ¥420.72B | 11.89 | 6.37% | 2.88% | 1.74% | 19.10% | |
74 Outperform | ¥526.52B | 8.11 | 8.58% | 2.62% | 8.21% | 72.79% | |
70 Outperform | ¥755.58B | 40.50 | 7.20% | 2.41% | 3.37% | -62.36% | |
65 Neutral | ¥18.46B | 7.15 | ― | 2.70% | -7.62% | 21.68% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
57 Neutral | ¥55.07B | 4.64 | ― | 0.99% | -0.22% | -2.98% |